Literature DB >> 11101087

Infection by zidovudine-resistant HIV-1 compromises the virological response to stavudine in a drug-naive patient.

A de Ronde, M van Dooren, E de Rooij, B van Gemen, J Lange, J Goudsmit.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 11101087     DOI： 10.1097/00002030-200011100-00038

Source DB:  PubMed          Journal:  AIDS        ISSN： 0269-9370            Impact factor:   4.177


× No keyword cloud information.
  3 in total

1.  Increased ability for selection of zidovudine resistance in a distinct class of wild-type HIV-1 from drug-naive persons.

Authors:  J G Garcia-Lerma; S Nidtha; K Blumoff; H Weinstock; W Heneine
Journal:  Proc Natl Acad Sci U S A       Date:  2001-11-06       Impact factor: 11.205

2.  A novel genetic pathway of human immunodeficiency virus type 1 resistance to stavudine mediated by the K65R mutation.

Authors:  J Gerardo García-Lerma; Hamish MacInnes; Diane Bennett; Patrick Reid; Soumya Nidtha; Hillard Weinstock; Jonathan E Kaplan; Walid Heneine
Journal:  J Virol       Date:  2003-05       Impact factor: 5.103

3.  Transmitted human immunodeficiency virus type 1 carrying the D67N or K219Q/E mutation evolves rapidly to zidovudine resistance in vitro and shows a high replicative fitness in the presence of zidovudine.

Authors:  J Gerardo García-Lerma; Hamish MacInnes; Diane Bennett; Hillard Weinstock; Walid Heneine
Journal:  J Virol       Date:  2004-07       Impact factor: 5.103
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.